title: Tyrosine kinase-dependent and -independent events induced by interleukin-2 stimulation: interleukin-2-mediated NO production required for the induction of lymphokine-activated killer cell activity in rat splenocytes is tyrosine kinase independent.
abstract: Nitric oxide (NO) has recently been shown to be an indispensable co-factor in the generation of lymphokine-activated killer (LAK) cells induced by interleukin-2 (IL-2). Upon stimulation with IL-2, cells endowed with specific receptors undergo phosphorylation of substrates mediated by protein tyrosine kinases (PTK). In this work we utilized a well-characterized PTK inhibitor, genistein (GEN), to address the role of PTK on NO-dependent LAK cell generation. The effects of GEN were tested on the expression of the inducible NO synthase (iNOS) gene, proliferation, generation of cytotoxic activity and production of NO upon IL-2 stimulation of rat splenocytes. We report here that GEN displays profound inhibitory effects on recombinant (r)IL-2 induced proliferation and on LAK cell generation, while only marginally affecting NO production, measured as NO2-. In contrast, a specific inhibitor of the NO synthetic pathway (NG-monomethyl-L-arginine; NMMA) blocked generation of LAK cells and NO production without affecting cell proliferation. If added directly to the cytotoxicity tests, GEN exerted minor inhibitory effects, not exceeding 25% of control tests, while NMMA was completely ineffective. Sodium nitroprusside (SNP), a non-enzymatic NO-releasing substance, restored LAK cell generation in cultures performed in the presence of NMMA, but not in those performed in the presence of GEN. These results indicate that IL-2-induced NO production is a PTK-independent event. IL-2-stimulated LAK cell generation obligatorily requires the concurrent activation of PTK dependent and independent signal transduction pathways.
authors.affiliation: Department of Surgery, University of Basel, Switzerland.
authors.forename: A
authors.initials: A
authors.lastname: Juretic
authors.forename: G C
authors.initials: GC
authors.lastname: Spagnoli
authors.forename: H
authors.initials: H
authors.lastname: Hörig
authors.forename: R
authors.initials: R
authors.lastname: Shipman
authors.forename: T
authors.initials: T
authors.lastname: Kocher
authors.forename: M
authors.initials: M
authors.lastname: Samija
authors.forename: M
authors.initials: M
authors.lastname: Turic
authors.forename: D
authors.initials: D
authors.lastname: Eljuga
authors.forename: F
authors.initials: F
authors.lastname: Harder
authors.forename: M
authors.initials: M
authors.lastname: Heberer
mesh_terms: D000818:Animals; D001483:Base Sequence; D002478:Cells, Cultured; D017931:DNA Primers; D005260:Female; D019833:Genistein; D007376:Interleukin-2 / Q000494:pharmacology*; D007529:Isoflavones / Q000494:pharmacology; D015979:Killer Cells, Lymphokine-Activated / Q000378:metabolism*; D008213:Lymphocyte Activation; D008969:Molecular Sequence Data; D009569:Nitric Oxide / Q000378:metabolism*; D016133:Polymerase Chain Reaction; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors / Q000378:metabolism*; D051381:Rats; D011916:Rats, Inbred F344; D013154:Spleen / Q000166:cytology; D013268:Stimulation, Chemical
chemical_list: D017931:DNA Primers; D007376:Interleukin-2; D007529:Isoflavones; D009569:Nitric Oxide; D019833:Genistein; D011505:Protein-Tyrosine Kinases